Mylan Urged by NYC Pension Fund to Name Independent Chairman

  • Comptroller criticizes ‘gross mismanagement’ of EpiPen prices
  • Letter to board member seeks oversight of pricing decisions

The New York City official in charge of protecting the city’s pension funds for teachers, firefighters, police and city employees wants Mylan NV to name an independent chairman, saying the recent controversy over the price of the EpiPen allergy shot is an example of the board’s failure to oversee risk.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.